Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based autologous stem cell therapy company. The Company has developed, patented, and is scaling a patient’s blood-based stem cell therapeutics platform, which includes angiogenic cell precursors, neuronal cell precursors and cardiomyocyte cell precursors. The Company holds 87 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01, its lead clinical-stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. ACP-01 is in a Phase 2 clinical trial in Canada and the United States. Its technology includes methods for collecting the synergetic cell population and manufacturing a personalized regenerative therapy that can be administered to a patient within seven days of the initial cell collection. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd. and PreCerv Inc.


TSXV:HEM - Post by User

Post by Pimpovishon Feb 10, 2021 11:01pm
254 Views
Post# 32534206

Monster positions vs big vs smallpositions-loose paper bleed

Monster positions vs big vs smallpositions-loose paper bleedI would say 20 out of 55.5 million shares out is in strong hands that have monster positions.
I'm thinking another 10 million is held by some level of big boy. These guys buy and hold. These numbers include insider ownership...Lacey, Smeenk et al. This leaves approx 25.5 million loose shares. We are seeing these loose shares bleed out. Waiting 3-4 months for a catalyst doesnt work for most smallcap investors looking for instant gratification. I really don't want more paper in this but these appallingly low prices are too tempting. I'm in this for a big win. There's still lots of risk but the upside is so much greater than the downside at these levels. 
<< Previous
Bullboard Posts
Next >>